Healius Ltd (ASX: HLS) Share Price and News

Dr Stanford AM is a Non-Executive Director across a range of industries including healthcare, aged care and education. His experience includes ASX-listed businesses, private equity backed companies and not for profit organisations, and includes dealing with Federal and State Governments Commencing his career as a Doctor, Michael progressed into hospital administration and brings over 20 years experience as a Chief Executive Officer and Managing Director of large multi-campus and multi service health care organisations with national and international areas of operation, including St John of God Health Care, Australian Hospital Care Ltd, North-Western Health. North-Eastern Health Care Network and Austin & Repatriation Medical Centre. Dr Stanford is a former Non-Executive Director of Healthscope, Virtus Health and Australian Clinical Labs. He is currently the Chair of Diabetes Australia and genU, a disability support service provider. He is also a board member for the Royal Australian College of General Practitioners.

Professor Mattick is a Professor in the School of Biotechnology and Biomolecular Science at UNSW Sydney. From 2018 to 2010, he was Chief Executive of Genomics England, which was established by the UK government to foster the use of genetic information in healthcare. He was Director of the Garvan Institute of Medical Research in Sydney from 2012 to 2018, where he established throughput NATA accredited DNA sequencing and genome analysis facilities. John was a member of the Australian Health Ethics Committee of the National Health & Medical Research Council from 1997 to 2003, an advisor to the Australian Law Reform Commission's Inquiry into the Protection of Human Genetic Information and Gene Patenting & Human Health, and the AHEC Committee to Revise the Ethical Guidelines on Assisted Reproductive Technology. He is a member of the Risk Management Committee.

Mr Davis has been an executive or non-executive director of ASX listed companies for 17 years. Before becoming a Non-Executive Director, he was Managing Director of AWB Limited between 2006 and 2010 and had a career, managing operating businesses in chemicals and agriculture. Gordon joined the Healius Board at a time of some corporate uncertainty, and has experience in governance and business transformation. He served as Policy Advisor to the federal Leader of the Opposition from 1990 to 1993 in the fields of environment, science and resources.

Ms McKenzie has experience in change management and digital transformation. She started her career in the public sector, where among other things, she was involved in aspects of health policy, including a state-based review of health system and re-negotiation of a Medicare agreement, and had involvement in working with Treasury on health budget allocations and methodologies. Kate joined Telstra in 2004 and held a range of executive roles in strategy, marketing, products and operations (responsible for networks, IT, field services and property). She was CEO of Chorus, a publicly listed NZ telco, for three years from 2017.She was appointed Chair of the Risk Management Committee in January 2023 and is a member of the People & Governance Committee.

Ms Evans has over 30 years of experience in private, government and social enterprise sectors and has worked in Australia, New Zealand, the United Kingdom and Hong Kong with responsibilities across the broader Asia Pacific region. With leadership experience, Sally moved to asset management in social infrastructure covering debt and equity raisings, investor relations, acquisitions and governance. She is Chair of the People & Governance Committee and a member of the Risk Management Committee.

Ms Jaquet has led efforts, generating substantial margin improvement and business growth. She has also established and managed international partnerships, and has commercial and operational line management experience across industrials and consumer sectors. Maxine's record at Healius includes leading the portfolio strategy which created a pure diagnostics business, building a dynamic leadership team, investing in edge technology, establishing and growing the private-billing general practitioner network, Health & Co. prior to its sale and leading two efficiency reviews with significant productivity gains

Mr Taylor has over 30 years of experience in advisory having recently retired as Senior Partner at McKinsey where he led the Health and Public Sector practices. He has advised many of Australia's private and public sector healthcare organisations on topics including strategy, digital, operations and growth transformations, global expansion and supply chains, mergers and acquisitions and board governance. Charlie initiated multi-year research efforts on healthcare, COVID response, productivity and innovation and has published articles and reports on healthcare reform lessons from around the globe. Charlie is currently a part-time senior board advisor at McKinsey for the Health and Public Sector practice, a Director of MacLauglin River Pastoral Company, a member of the strategic advisory committee For Purpose Investment Partners and was recently appointed as Chair of the NSW Innovation and Productivity Commission. Charlie is the Honorary Federal Treasurer for the Liberal Party and a Board member on the Federal Executive. is a member of the People & Governance Committees.

--

-

-

-

-

-

-

-

-

-

-

-

-

-